Colgate Palmolive Co

Company facts

Industry

Perfumes, Cosmetics & Other Toilet Preparations

Headquarters

New York, New York

Most recent report

10-Q, filed Oct 30, 2026

Incorporated

Delaware

Filings on record

1,003+ filings

On EDGAR

CIK 21665

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Sep 2026 10-Q

SECSift found 2 of 9 sections worth reading, with 2 positive, 6 notable, and 2 negative flags.

• Part I

  Full financial statements, segment detail, restructuring charges, litigation, and tax dispute.
  Positive

  • Latin America net sales up 12.5% in Q3 2026; operating profit up 17% to $392M.
  Notable

  • Q3 2026 net sales up 4.6% to $5,369M; organic sales up 3.6%.
  • Advertising investment rose 15% to $775M in Q3 2026, from $674M in Q3 2025.
  • GAAP operating profit margin fell 30 bps to 20.3%; non-GAAP margin rose 20 bps to 20.8%.
  • North America net sales fell 1.7% in Q3 2026; organic sales down 1.6%.
  • Net cash from operations up 6% to $2,913M in 9M 2026; share repurchases $927M.
  • Total debt decreased to $7,716M at Sep 30, 2026 from $7,988M at Dec 31, 2025.
  Negative

  • Talc lawsuits: 561 cases pending at Sep 30, 2026, up from 453 at Dec 31, 2025.
  • IRS tax dispute for 2010-2021 estimated at ~$170M, not included in uncertain tax positions.

• Unregistered Sales and Repurchases (Item 2)

  New $5B buyback authorization and Q3 2026 repurchase activity with prices and remaining capacity.
  Positive

  • New $5B buyback program authorized March 2025, replacing prior program; $3.2B remained at Q3 2026 end.

What changed: Sep 2026 vs. Jun 2026

About 3% of CL's Sep 2026 10-Q is new information. 11 paragraphs were added, 186 changed, and 32 removed. Below are the most important lines SECSift identified.

• Part I 117
• Item 6 11
• Item 2 3
• Item 1A 1
• Item 5 1